IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MEOLA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.589
NA - Nord America 15.897
AS - Asia 11.713
SA - Sud America 1.270
AF - Africa 211
OC - Oceania 115
Continente sconosciuto - Info sul continente non disponibili 7
Totale 45.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.287
GB - Regno Unito 5.141
IT - Italia 3.688
CN - Cina 3.639
SG - Singapore 3.410
DE - Germania 1.592
RU - Federazione Russa 1.250
SE - Svezia 1.102
HK - Hong Kong 1.023
BR - Brasile 858
FR - Francia 830
VN - Vietnam 758
IN - India 619
TR - Turchia 577
UA - Ucraina 573
NL - Olanda 548
KR - Corea 489
IE - Irlanda 471
FI - Finlandia 459
CA - Canada 455
EU - Europa 304
JP - Giappone 299
BD - Bangladesh 236
ID - Indonesia 206
CO - Colombia 193
ES - Italia 184
PL - Polonia 111
BE - Belgio 101
GR - Grecia 97
MX - Messico 97
AU - Australia 96
AR - Argentina 72
CH - Svizzera 62
DK - Danimarca 55
IQ - Iraq 54
PH - Filippine 54
PT - Portogallo 54
TW - Taiwan 50
RO - Romania 46
CZ - Repubblica Ceca 42
ZA - Sudafrica 42
AT - Austria 38
PK - Pakistan 37
CI - Costa d'Avorio 35
EC - Ecuador 35
CL - Cile 34
MY - Malesia 34
EG - Egitto 31
NO - Norvegia 31
UZ - Uzbekistan 30
VE - Venezuela 26
IR - Iran 25
IL - Israele 23
PE - Perù 23
SA - Arabia Saudita 22
HU - Ungheria 21
TN - Tunisia 21
RS - Serbia 19
KE - Kenya 18
PY - Paraguay 18
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
TH - Thailandia 15
BG - Bulgaria 14
DZ - Algeria 12
JO - Giordania 12
KZ - Kazakistan 11
SI - Slovenia 11
AZ - Azerbaigian 10
HR - Croazia 10
MA - Marocco 10
CR - Costa Rica 9
NP - Nepal 9
HN - Honduras 8
JM - Giamaica 8
LU - Lussemburgo 8
AL - Albania 7
BY - Bielorussia 7
BJ - Benin 6
BO - Bolivia 6
LB - Libano 6
OM - Oman 6
QA - Qatar 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
PA - Panama 5
SN - Senegal 5
UY - Uruguay 5
AM - Armenia 4
CY - Cipro 4
KG - Kirghizistan 4
LV - Lettonia 4
PS - Palestinian Territory 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
EE - Estonia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 46.040
Salva come PNG Salva come JPEG
Città #
Southend 4.474
Singapore 1.840
Ashburn 1.240
Chandler 1.120
Seattle 971
Hong Kong 950
Milan 907
San Jose 815
Beijing 709
Fairfield 662
Princeton 656
Wilmington 614
Dublin 458
Council Bluffs 449
Dallas 403
Jacksonville 397
Woodbridge 395
Dearborn 378
Mountain View 326
Houston 321
Ann Arbor 317
Redmond 307
Los Angeles 291
Cambridge 270
Bengaluru 269
Nanjing 254
Lauterbourg 234
Santa Clara 229
Rome 226
Redwood City 225
Somerville 223
Ho Chi Minh City 219
Serra 208
Toronto 208
Sakarya 190
New York 186
Guangzhou 181
Hefei 177
Hanoi 176
Helsinki 174
Des Moines 168
Frankfurt am Main 167
Boardman 164
Bogotá 162
Moscow 162
Andover 158
Buffalo 154
Shanghai 142
The Dalles 125
Columbus 118
Tokyo 118
Jakarta 117
Pisa 111
Hamburg 96
Jinan 95
Phoenix 95
Shenyang 93
Eitensheim 90
Athens 88
Cangzhou 86
Nanchang 80
Warsaw 79
Berlin 77
Seoul 77
São Paulo 75
London 71
Sunnyvale 68
Tianjin 68
Ottawa 64
Changsha 61
Medford 61
Munich 60
Shenzhen 55
Brussels 54
Turin 54
Chicago 53
Hanover 53
Hebei 53
Bologna 52
San Diego 50
Vigo 49
Grafing 46
Bitonto 42
Hangzhou 42
Falls Church 39
Washington 38
Dong Ket 37
Jiaxing 36
Abidjan 35
Boston 35
Nuremberg 35
Odernheim 35
Norwalk 33
Taipei 33
Florence 32
Duncan 31
Haiphong 31
Naples 31
Salt Lake City 31
Silver Spring 31
Totale 27.145
Salva come PNG Salva come JPEG
Nome #
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 699
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 634
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 583
Cerebral involvement in myotonic dystrophies 558
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 511
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 510
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 459
Andersen's syndrome : a distinct periodic paralysis 455
DM1, DM2 e paralisi periodiche : diagnosi e terapia 443
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 442
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 419
La canalopatia del cloro : diagnosi clinica differenziale 383
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 370
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 352
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 343
Treatment for periodic paralysis 341
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 319
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 318
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 316
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 303
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 298
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 281
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 280
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 280
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 280
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 279
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 275
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 269
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 264
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 261
Therapy in myotonic disorders and in muscle channelopathies 261
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 261
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 259
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 257
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 247
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 246
Persistent autobiographical amnesia: a case report 243
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 242
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 242
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 241
Oculopharyngeal muscular dystrophy in Italy. 237
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 237
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 237
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 236
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 234
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 233
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 233
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 232
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 232
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 231
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 222
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 221
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 219
Lezioni di Traumatologia 218
The role of clinical and neuroimaging features in the diagnosis of CADASIL 218
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 217
Muscle cramps, insuline resistance, acanthosis nigricans and acral hypertrphy sindrome : a potentially treatable condition 216
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 215
Consensus-based care recommendations for adults with myotonic dystrophy type 1. 214
A CASE OF MITOCHONDRIAL MYOPATHY, LACTIC-ACIDOSIS AND COMPLEX-I DEFICIENCY 212
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 210
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 208
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 206
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 206
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 206
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 205
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 204
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 203
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 201
Quantitative myotonia assessment: an experimental protocol 200
Biomolecular diagnosis of myotonic dystrophy type 2 : a challenging approach 200
Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1 197
Clinical Reasoning : a 35-year-old woman with hyperstartling, stiffness, and accidental falls : a startling diagnosis 197
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 196
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 194
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 194
New mutations in SCN4A and their biophysical properties 194
Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis 192
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 192
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies 190
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 188
Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy 188
Rare Disease : Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 186
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 183
Migraine and patent foramen ovale: improvement after transcatheteral closure 182
Cerebrospinal fluid (CSF) Tau and amyloid Beta42 (AB42) protein abnormalities correlate with executive dysfuction in Myotonic Dystrophy Type 1 (DM1) and Type 2 (DM2) 182
A multidisciplinary approach improves quality of life perception in patients with amyotrophic lateral sclerosis 182
High prevalence of vitamin D deficiency in myotonic dystrophies 181
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2 180
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 179
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 179
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism 179
Neuroimaging in the early diagnosis of Krabbe leukodystrophy types 1 and 2 178
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 178
[Expression of a defect in the respiratory chain in cultured human cells] 178
RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1 178
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 177
Muscle surface mechanical and electrical activities in myotonic dystrophy 177
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2 : an immunocytochemical study 177
Human skeletal muscle sodium channelopathies 174
Totale 26.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.048 0 0 0 0 0 0 0 0 0 0 814 234
2021/20223.278 268 126 211 121 238 283 293 135 312 371 276 644
2022/20233.956 568 331 369 463 463 697 141 242 366 73 150 93
2023/20242.362 99 189 148 98 509 177 85 150 75 221 246 365
2024/20255.613 280 612 143 441 393 252 257 636 314 511 572 1.202
2025/202611.050 1.112 770 1.308 849 1.051 884 1.348 771 1.287 993 677 0
Totale 48.144